# A Study of PJ009 in Healthy Adult Volunteers

> **NCT06523101** · PHASE1 · COMPLETED · sponsor: **Chongqing Peg-Bio Biopharm Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** PJ009
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06523101
- **Lead sponsor:** Chongqing Peg-Bio Biopharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-28
- **Primary completion:** 2023-05-15
- **Final completion:** 2023-05-15
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06523101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06523101, "A Study of PJ009 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06523101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*